ESPE Abstracts

Introduction: Thiamine-responsive megaloblastic anemia syndrome (TRMA) a rare autosomal recessive condition described by megaloblastic anemia, diabetes mellitus and progressive sensorineural hearing loss. The onset occurs between infancy and adolescence. Thiamine treatment correct the anemia, but the red blood cells remain macrocytic; the anemia can recur when thiamine treatment seized. Progressive sensorineural hearing loss can be started early in kids; it is...